Clinical Trial Results

A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

PHASE3INTERVENTIONAL Pheonix, Arizona +4 more

RECRUITING

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

PHASE3INTERVENTIONAL Cullman, Alabama +4 more

RECRUITING

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

N/AOBSERVATIONAL Birmingham, Alabama +4 more

RECRUITING

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

PHASE3INTERVENTIONAL Scottsdale, Arizona +4 more

RECRUITING

A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)

PHASE2INTERVENTIONAL Atlanta, Georgia +2 more

RECRUITING

Retinal Imaging in Neurodegenerative Disease

N/AOBSERVATIONAL Durham, North Carolina

RECRUITING

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

PHASE3INTERVENTIONAL Palo Alto, California +4 more

RECRUITING

Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)

N/AOBSERVATIONAL Aurora, Colorado +4 more

RECRUITING

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

PHASE1, PHASE2INTERVENTIONAL La Jolla, California +4 more

RECRUITING

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

PHASE2INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING